vs
INTELLIGENT PROTECTION MANAGEMENT CORP.（IPM）与Protalix BioTherapeutics, Inc.（PLX）财务数据对比。点击上方公司名可切换其他公司
Protalix BioTherapeutics, Inc.的季度营收约是INTELLIGENT PROTECTION MANAGEMENT CORP.的1.5倍（$9.1M vs $6.1M），INTELLIGENT PROTECTION MANAGEMENT CORP.同比增速更快（2091.6% vs -49.9%），过去两年INTELLIGENT PROTECTION MANAGEMENT CORP.的营收复合增速更高（54.7% vs -6.7%）
智能防护管理公司是一家总部位于英国格洛斯特郡的控股母公司，于2008年5月21日完成注册。公司为旗下四家子公司提供集团管理架构，其前身是专精于情报搜集、反间谍与反窃听检测业务的国际情报有限公司。
Protalix BioTherapeutics是一家以色列制药企业，核心产品为植物源酶制剂他利苷酶阿尔法，该产品已获美国食品药品监督管理局批准，用于治疗戈谢病，专注于开发创新生物技术药物服务患者需求。
IPM vs PLX — 直观对比
营收规模更大
PLX
是对方的1.5倍
$6.1M
营收增速更快
IPM
高出2141.5%
-49.9%
两年增速更快
IPM
近两年复合增速
-6.7%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $6.1M | $9.1M |
| 净利润 | — | $-5.5M |
| 毛利率 | 53.1% | 49.4% |
| 营业利润率 | -13.4% | -51.1% |
| 净利率 | — | -60.3% |
| 营收同比 | 2091.6% | -49.9% |
| 净利润同比 | — | -184.8% |
| 每股收益（稀释后） | $-0.05 | $-0.06 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收IPMPLX
| Q4 25 | $6.1M | $9.1M | ||
| Q3 25 | $6.2M | $17.9M | ||
| Q2 25 | $5.7M | $15.7M | ||
| Q1 25 | $5.5M | $10.1M | ||
| Q4 24 | — | $18.2M | ||
| Q3 24 | — | $18.0M | ||
| Q2 24 | — | $13.5M | ||
| Q4 23 | $-7.3M | $10.5M |
净利润IPMPLX
| Q4 25 | — | $-5.5M | ||
| Q3 25 | $-1.1M | $2.4M | ||
| Q2 25 | $-1.1M | $164.0K | ||
| Q1 25 | $808.5K | $-3.6M | ||
| Q4 24 | — | $6.5M | ||
| Q3 24 | — | $3.2M | ||
| Q2 24 | — | $-2.2M | ||
| Q4 23 | — | $-6.0M |
毛利率IPMPLX
| Q4 25 | 53.1% | 49.4% | ||
| Q3 25 | 50.7% | 53.4% | ||
| Q2 25 | 50.1% | 62.5% | ||
| Q1 25 | 55.3% | 19.1% | ||
| Q4 24 | — | 78.7% | ||
| Q3 24 | — | 53.4% | ||
| Q2 24 | — | 29.8% | ||
| Q4 23 | — | 15.5% |
营业利润率IPMPLX
| Q4 25 | -13.4% | -51.1% | ||
| Q3 25 | -23.0% | 11.9% | ||
| Q2 25 | -19.7% | 7.5% | ||
| Q1 25 | -24.2% | -41.0% | ||
| Q4 24 | — | 39.6% | ||
| Q3 24 | — | 22.2% | ||
| Q2 24 | — | -18.0% | ||
| Q4 23 | — | -53.5% |
净利率IPMPLX
| Q4 25 | — | -60.3% | ||
| Q3 25 | -17.4% | 13.2% | ||
| Q2 25 | -18.3% | 1.0% | ||
| Q1 25 | 14.7% | -35.8% | ||
| Q4 24 | — | 35.6% | ||
| Q3 24 | — | 18.0% | ||
| Q2 24 | — | -16.4% | ||
| Q4 23 | — | -57.6% |
每股收益（稀释后）IPMPLX
| Q4 25 | $-0.05 | $-0.06 | ||
| Q3 25 | $-0.08 | $0.03 | ||
| Q2 25 | $-0.08 | $0.00 | ||
| Q1 25 | $0.06 | $-0.05 | ||
| Q4 24 | — | $0.10 | ||
| Q3 24 | — | $0.03 | ||
| Q2 24 | — | $-0.03 | ||
| Q4 23 | $-0.03 | $-0.03 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $5.6M | $14.7M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $18.2M | $48.2M |
| 总资产 | $26.0M | $82.3M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资IPMPLX
| Q4 25 | $5.6M | $14.7M | ||
| Q3 25 | $7.3M | $13.6M | ||
| Q2 25 | $7.3M | $17.9M | ||
| Q1 25 | $9.7M | $19.5M | ||
| Q4 24 | — | $19.8M | ||
| Q3 24 | — | $27.4M | ||
| Q2 24 | — | $23.4M | ||
| Q4 23 | $13.6M | $23.6M |
股东权益IPMPLX
| Q4 25 | $18.2M | $48.2M | ||
| Q3 25 | $18.8M | $52.9M | ||
| Q2 25 | $19.9M | $49.9M | ||
| Q1 25 | $21.1M | $45.2M | ||
| Q4 24 | — | $43.2M | ||
| Q3 24 | — | $32.4M | ||
| Q2 24 | — | $28.6M | ||
| Q4 23 | $20.1M | $33.6M |
总资产IPMPLX
| Q4 25 | $26.0M | $82.3M | ||
| Q3 25 | $27.2M | $82.3M | ||
| Q2 25 | $29.8M | $78.5M | ||
| Q1 25 | $31.1M | $73.9M | ||
| Q4 24 | — | $73.4M | ||
| Q3 24 | — | $61.6M | ||
| Q2 24 | — | $91.5M | ||
| Q4 23 | $23.9M | $84.4M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $87.6K | $2.0M |
| 自由现金流经营现金流 - 资本支出 | — | $1.6M |
| 自由现金流率自由现金流/营收 | — | 17.8% |
| 资本支出强度资本支出/营收 | — | 4.4% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | $-13.6M |
8季度趋势，按日历期对齐
经营现金流IPMPLX
| Q4 25 | $87.6K | $2.0M | ||
| Q3 25 | $133.0K | $-3.7M | ||
| Q2 25 | $-888.7K | $-5.2M | ||
| Q1 25 | $1.7M | $-5.1M | ||
| Q4 24 | — | $4.0M | ||
| Q3 24 | — | $4.1M | ||
| Q2 24 | — | $-3.6M | ||
| Q4 23 | $-99.0K | $3.6M |
自由现金流IPMPLX
| Q4 25 | — | $1.6M | ||
| Q3 25 | — | $-4.2M | ||
| Q2 25 | — | $-5.7M | ||
| Q1 25 | — | $-5.4M | ||
| Q4 24 | — | $3.6M | ||
| Q3 24 | — | $4.0M | ||
| Q2 24 | — | $-3.8M | ||
| Q4 23 | — | $3.3M |
自由现金流率IPMPLX
| Q4 25 | — | 17.8% | ||
| Q3 25 | — | -23.7% | ||
| Q2 25 | — | -36.2% | ||
| Q1 25 | — | -53.0% | ||
| Q4 24 | — | 19.6% | ||
| Q3 24 | — | 22.4% | ||
| Q2 24 | — | -28.1% | ||
| Q4 23 | — | 31.9% |
资本支出强度IPMPLX
| Q4 25 | — | 4.4% | ||
| Q3 25 | 0.0% | 2.8% | ||
| Q2 25 | — | 2.8% | ||
| Q1 25 | — | 3.0% | ||
| Q4 24 | — | 2.3% | ||
| Q3 24 | — | 0.5% | ||
| Q2 24 | — | 1.3% | ||
| Q4 23 | — | 2.4% |
现金转化率IPMPLX
| Q4 25 | — | — | ||
| Q3 25 | — | -1.58× | ||
| Q2 25 | — | -31.91× | ||
| Q1 25 | 2.16× | — | ||
| Q4 24 | — | 0.61× | ||
| Q3 24 | — | 1.27× | ||
| Q2 24 | — | — | ||
| Q4 23 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
IPM
| Procurement Revenue | $5.4M | 88% |
| Other | $743.9K | 12% |
PLX
| Products | $8.7M | 95% |
| Other | $428.0K | 5% |
